Skip to main content
CHE
NYSE Industrial Applications And Services

Chemed Beats Q2 Estimates, Raises Full-Year Guidance on Hospice Strength

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$540
Mkt Cap
$7.099B
52W Low
$365.205
52W High
$551.68
52W Position info
48% above low
Off High info
2.1% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

CHE sits 48% above its 52-week low of $365.205.

Summary

Chemed beat Q2 2026 estimates and raised full-year guidance, fueled by VITAS hospice segment outperformance and aggressive share repurchases.


Key Events · Earnings and Guidance · CHE

  • Q2 Earnings Beat

    Revenue of $673.3M beat consensus of $665M; adjusted EPS of $6.06 beat consensus of $5.60.

  • Full-Year Guidance Raised

    Management raised full-year guidance, citing strong VITAS hospice segment performance.

  • VITAS Segment Drives Growth

    VITAS revenue grew 11.9% on a 6.1% increase in days-of-care and a 2.4% Medicare rate increase.

  • Aggressive Share Repurchases

    Company repurchased $287.5M in shares during H1 2026, with $139.8M remaining under authorization.


Analysis · CHE · Industrial Applications And Services

Chemed delivered a strong Q2 beat with revenue of $673.3M vs. $665M consensus and adjusted EPS of $6.06 vs. $5.60, driven by VITAS hospice segment outperformance. The company raised full-year guidance, signaling confidence in sustained momentum. Aggressive share repurchases ($287.5M in H1) and a new $450M credit facility underscore a robust capital allocation strategy. The results come amid activist pressure from Barington Capital for a strategic review, adding a layer of urgency to the operational outperformance.

How filings like this one have moved

In the 30 days to Aug 25, 2026, 37.4% of the 3413 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CHE was trading at $540.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $7.1B. The 52-week trading range was $365.21 to $551.68. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CHE - Latest Insights

CHE
Jul 28, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $530.37
Real-time Price: $539.90 info
Change: +$9.53 (+2%) info
Market Cap: $7.056B info
CHE
Jul 28, 2026, 4:28 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $530.37
Real-time Price: $539.90 info
Change: +$9.53 (+2%) info
Market Cap: $7.056B info
CHE
Jul 21, 2026, 8:15 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $515.11
Real-time Price: $539.90 info
Change: +$24.79 (+5%) info
Market Cap: $7.056B info
CHE
May 19, 2026, 10:43 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $443.20
Real-time Price: $539.90 info
Change: +$96.70 (+22%) info
Market Cap: $7.056B info
CHE
Apr 28, 2026, 9:00 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $422.72
Real-time Price: $539.90 info
Change: +$117.18 (+28%) info
Market Cap: $7.056B info